Boston Medical Center
426
40
56
269
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.3%
78 terminated/withdrawn out of 426 trials
77.5%
-9.0% vs industry average
8%
35 trials in Phase 3/4
34%
91 of 269 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (426)
Infectious Disease (ID) Testing OUtreach in Carceral Hubs
Role: lead
Implementing a Pilot Patient Navigator Program to Improve Access to Infertility Care for Underserved Patients
Role: lead
Glaucoma Drop Aids Part 2
Role: lead
Cardiac Anodal Biphasic Pacing
Role: lead
Clinician Practice Companion to Address Youth Substance Use
Role: collaborator
Neural Mechanisms of Spatial Representations Beyond the Self
Role: collaborator
Heart Failure Self Care Education in Rwanda
Role: lead
Skilled Nursing Facility Care at Home
Role: collaborator
Training Early Social Language in Autism
Role: collaborator
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
Role: collaborator
Anti-Interleukin-6 (IL6) in Calciphylaxis
Role: lead
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Role: collaborator
HERE: Health Empowerment and Resources After Pregnancy
Role: lead
Stepped Care for Posttraumatic Stress Disorder Study
Role: lead
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
Role: lead
VIGOR: Virtual Genome Center for Infant Health
Role: collaborator
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Role: collaborator
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Role: lead
Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients
Role: lead
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Role: collaborator